AXP vs FBLG · P/E 20, rev $21.73B vs $24.0M cap
American Express Company (AXP) versus FibroBiologics, Inc. Common Stock (FBLG) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
FBLG does not have a complete income-statement cache yet.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. FBLG currently screens at market cap $24.0M.
Not investment advice. Open the AXP and FBLG stock pages for the full models.
Not investment advice.